Skip to content

ATTEND-Family-led Rehabilitation After Stroke in India

Family-led Rehabilitation After Stroke in India

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02123875
Acronym
ATTEND
Enrollment
104
Registered
2014-04-28
Start date
2011-12-31
Completion date
2013-03-31
Last updated
2014-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Brief summary

ATTEND Trial is based on early supported discharge- home based stroke rehabilitation model which proves to offer several advantages in low and mid income countries. The objectives of the pilot stude were to determine that with a randomized blinded outcome assessor, controlled trial, family- led caregiver- delivered home based rehabilitation is better than usual care for those with disabling stroke in India and the feasibility of this model.

Interventions

OTHERPhysiotherapy
OTHERControl arm

Routine hospital based physiotherapy

Sponsors

The George Institute for Global Health, Australia
CollaboratorOTHER
Christian Medical College and Hospital, Ludhiana, India
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults (\>18 years) * Recent (\<1 month) acute ischaemic/haemorrhagic/ undifferentiated stroke * Residual disability (requiring help from another person for everyday activities) * Expected to survive to discharge from hospital with a reasonable expectation of six month survival * Able (or by proxy) to provide informed consent

Exclusion criteria

* Unable to identify a suitable family - nominated caregiver for training and subsequent delivery of care * Those unwilling/unable to adhere to follow up.

Design outcomes

Primary

MeasureTime frame
Change in modified Rankin Score3rd and 6th month

Countries

India

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 18, 2026